Eric Lacoste, Ph.D

Head of ADC Conjugation Development

Based in the greater Paris Metropolitan Region of France, Eric joined Sanofi in 2007 to develop ADC Drug Substance processes. As head of the ADC Conjugation Development team at Sanofi he is in charge of supervising process development for Drug Substance protein conjugates to support research programs up to commercial launch readiness.

Eric's activities encompass DS process transfer, cGMP manufacturing overseeing, Regulatory Dossier writing and Due Diligence as well as interface with different CMC functions. Eric has a Ph.D in Organic Chemistry.

In addition to his role as of the ADC Conjugation Development team, Eric supports different initiatives to implement new ways of working as well as developing and implementing novel technologies.